Lilly announces three acquisitions to build infectious disease portfolio

Health

Lilly Announces Three Acquisitions To Build Infectious Disease Portfolio

By investor.lilly.com

Agreements with Curevo, LimmaTech Biologics and Vaccine Company address viral pathogens linked to long-term neurological and oncological risk, and bacterial pathogens that are difficult to prevent or treat Acquisitions build on Lilly's infectious dis ...Read more

Related Posts

Vegan College Student Dies by Suicide. Experts Say Her Mental Decline Was a 'Direct Result' of Her Diet

Vegan College Student Dies by Suicide. Experts Say Her Mental Decline Was a 'Direct Result' of Her Diet

May 20, 2026
Ronda Rousey responds to Holly Holm, claims she would ‘clean her clock’ in a rematch but insists ‘I’m retired’

Ronda Rousey responds to Holly Holm, claims she would ‘clean her clock’ in a rematch but insists ‘I’m retired’

May 28, 2026
Study finds deadly hantavirus more widespread in Pacific Northwest rodents than expected

Study finds deadly hantavirus more widespread in Pacific Northwest rodents than expected

May 21, 2026
Is hantavirus like COVID-19? Five infectious disease experts answer some of the biggest questions about the outbreak.

Is hantavirus like COVID-19? Five infectious disease experts answer some of the biggest questions about the outbreak.

May 14, 2026
We use cookies to help provide you with the best experience when you visit our websites. By using this site you consent to the use of cookies on your device. see our cookie policy.